FIELD: chemistry; pharmacology.
SUBSTANCE: group of inventions relates to chemistry and pharmacology, namely to a peptide with antibacterial activity or a pharmaceutically acceptable salt thereof, having the sequence SEQ ID NO: 1; to its use as an antibacterial agent; to its use for preparing a pharmaceutical composition with antibacterial activity for treating and/or preventing an infectious disease in a subject caused by a bacterial infection; to a pharmaceutical composition with antibacterial activity for treating and/or preventing an infectious disease in a subject caused by a bacterial infection, containing an effective amount of the disclosed peptide and at least one pharmaceutically acceptable excipient.
EFFECT: group of inventions provides a wider range of antibacterial agents for treating infectious diseases, including those caused by multidrug-resistant bacterial strains.
14 cl, 3 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDES WITH ANTIBACTERIAL ACTIVITY | 2023 |
|
RU2811267C1 |
| USE OF 6-FLUORO-3-TRIAZENONE INDOLES FOR THERAPY OF INFECTIONS CAUSED BY MRSA | 2019 |
|
RU2712265C1 |
| METHOD FOR THE TREATMENT AND PREVENTION OF RECURRENCE OF NOSOCOMIAL PNEUMONIA | 2021 |
|
RU2794585C2 |
| MODIFIED ENDOLYSIN AND ANTIBACTERIAL COMPOSITIONS BASED THEREON FOR TREATING INFECTIONS CAUSED BY ACINETOBACTER BAUMANNII, PSEUDOMONAS AERUGINOSA, KLEBSIELLA PNEUMONIAE, ESCHERICHIA COLI BACTERIA | 2023 |
|
RU2813626C1 |
| POLYPEPTIDE WITH ANTIBACTERIAL ACTIVITY, COMPOSITION FOR THE PREVENTION OR TREATMENT OF SEPSIS WHICH INCLUDES IT, AND ANTIBACTERIAL COMPOSITION | 2020 |
|
RU2797347C2 |
| PEPTIDES AND USE THEREOF | 2011 |
|
RU2590706C2 |
| METHOD FOR PREVENTION OF HEALTHCARE-ASSOCIATED INFECTIONS IN PATIENTS IN CHRONIC CRITICAL CONDITION | 2023 |
|
RU2818910C1 |
| POLYMYXIN DERIVATIVES AND THEIR USE | 2016 |
|
RU2675819C1 |
| ANTIBACTERIAL COMPOSITION (EMBODIMENTS) AND USE OF PROTEIN AS ANTIMICROBIAL AGENT DIRECTED AGAINST BACTERIA PSEUDOMONAS AERUGINOSA, KLEBSIELLA PNEUMONIAE, ESCHERICHIA COLI, SALMONELLA TYPHI AND STAPHYLOCOCCUS HAEMOLYTICUS (EMBODIMENTS) | 2019 |
|
RU2730614C1 |
| ANTIBACTERIAL COMPOSITION (EMBODIMENTS) AND USE OF PROTEIN AS ANTIMICROBIAL AGENT DIRECTED AGAINST BACTERIA PSEUDOMONAS AERUGINOSA, KLEBSIELLA PNEUMONIAE, ESCHERICHIA COLI, SALMONELLA TYPHI AND STAPHYLOCOCCUS HAEMOLYTICUS (EMBODIMENTS) | 2019 |
|
RU2730613C1 |
